Trailing-twelve-month (TTM) revenue is $6.04 Billion with a year-over-year growth of +8.37%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $1,460,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q3 FY2026Period ended 2025-12-31 | $1,496,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-06 |
| Q4 FY2026Period ended 2026-03-31 | $1,588,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-29 |
| Q1 FY2027Period ended 2026-06-30 | $1,492,700,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $6,037,500,000 |
Current P/S: $20,346,244,029 market capitalization ÷ $6,037,500,000 TTM revenue = 3.37x.
Market capitalization source: FMP quote. Quote observed 2026-09-24T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $1.49B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-25T00:16:02.235Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Product | $1.4B | $2.6B | $2.8B | $2.8B | $2.9B | $3.1B |
| Service | $1.7B | $2.0B | $2.2B | $2.4B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| IRELAND | $72M | $82M | $74M | $83M | $107M | $109M |
| Other foreign locations | $809M | $1.3B | $1.3B | $1.3B |
$6.04B
$6.04 Billion
+8.37%
vs. $5.57B a year ago (TTM)
+12.13%
5 Year compound annual growth rate
1 Year
+8.37%
3 Year
+6.59%
5 Year
+12.13%
10 Year
+9.50%
15 Year
+10.57%
20 Year
+8.61%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $5.94B | +$476.38M | +8.73% |
| 2025 | $5.46B | +$320.81M | +6.24% |
| 2024 | $5.14B | +$602.43M | +13.28% |
| 2023 | $4.54B | +$312.86M | +7.41% |
| 2022 | $4.22B | +$1.12B | +35.91% |
| 2021 |
TTM Growth
+8.37%
3-Year CAGR
+6.59%
5-Year CAGR
+12.13%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-25T00:16:02.235Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $2.9B |
| $1.5B |
| UNITED STATES | $2.2B | $3.2B | $3.6B | $3.8B | $4.0B | $4.3B |
|---|
| $3.11B |
| +$76.62M |
| +2.53% |
| 2020 | $3.03B | +$248.72M | +8.94% |
| 2019 | $2.78B | +$162.17M | +6.19% |
| 2018 | $2.62B | +$7.24M | +0.28% |
| 2017 | $2.61B | +$373.99M | +16.71% |
